Last reviewed · How we verify

NCT04556500

Turkish Version of the Affordance in the Home Environment for Motor Development-Toddler (AHEMD-T)

Completed Last updated 22 June 2022
What this trial tests

trial testing investigating the psychometric properties of Turkish Affordance in the Home Environment for Motor Development-Toddler (AHEMD-T) in Musculoskeletal Diseases in 139 participants. Completed in 15 January 2022.

Timeline
1 October 2020
Primary endpoint
1 April 2021
15 January 2022

Quick facts

Lead sponsorHacettepe University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment139
Start date1 October 2020
Primary completion1 April 2021
Estimated completion15 January 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 18 Months to 42 Months, any sex, with Musculoskeletal Diseases or Genetic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to translate the Affordance in the Home Environment for Motor Development -Toddler (AHEMD-T) into Turkish and examine its psychometric properties.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Musculoskeletal Diseases

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04556500.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing